MAP Online Tools

A suite of best-in-class Market Access tools that save you time in planning, used regularly by our consultants these tools are practical and comprehensive. Available to MAP Online members as part of the membership fee, or at a highly subsidised rate. Tools can also be purchased for a one-off fee by non-MAP Online members.

International Reference Pricing (IRP) Model

What is the IRP Model?

 A proven way to stress test your pricing strategy across global markets

It measures the impact of reference pricing rules across 43 countries including the likelihood and extent of parallel trade:
- Select country references
- Adjust pricing variables
- Forecast 10-year revenue

The IRP model helps companies understand how reference pricing and parallel trade can impact product revenues and allows them to determine the optimal launch sequence for new medicines. Our easy to use and dynamic model helps companies through this decision-making process. All of the model inputs can be varied to enable companies to quickly run multiple scenarios in order to determine their optimal commercial strategy. The model provides quarterly revenue forecasts up to 10 years into the future. Complete modelling of the impact of reference pricing rules on the main global markets including the likelihood and extent of parallel trade

Who is it for?

 Market Access and Commercial professionals

When would this tool be used?

 Any time in the product life-cycle from design of phase II trials to beyond market authorisation, pricing & reimbursement. However, the most impactful stages are:

- At horizon scanning engagement with pricing & reimbursement bodies to help sequence launches across markets
- Throughout implementation of submission plans in countries, to help plan for and mitigate short-term risks in referencing that can have long-term consequences

How does the tool help?

 Avoid surprises for Boards of management e.g., supply shortages due to unanticipated parallel trade and price erosion

 Supports planning, to mitigate short term risks in referencing that can have long term consequences

 Peace of mind as validation of your assumptions and business decisions

Tool price

 MAP Online member fee: £12,000, non-member fee: £25,000

MAP Online
MAP Online Tools
MAP Online Tools

International Reference Pricing (IRP) Model

What is it?

A proven way to stress test your pricing strategy across global markets

It measures the impact of reference pricing rules across 43 countries including the likelihood and extent of parallel trade:
- Select country references
- Adjust pricing variables
- Forecast 10-year revenue

The IRP model helps companies understand how reference pricing and parallel trade can impact product revenues and allows them to determine the optimal launch sequence for new medicines. Our easy to use and dynamic model helps companies through this decision-making process. All of the model inputs can be varied to enable companies to quickly run multiple scenarios in order to determine their optimal commercial strategy. The model provides quarterly revenue forecasts up to 10 years into the future. Complete modelling of the impact of reference pricing rules on the main global markets including the likelihood and extent of parallel trade

Who is it for?

Market Access and Commercial professionals

When would it be used?

 Any time in the product life-cycle from design of phase II trials to beyond market authorisation, pricing & reimbursement. However, the most impactful stages are:

- At horizon scanning engagement with pricing & reimbursement bodies to help sequence launches across markets
- Throughout implementation of submission plans in countries, to help plan for and mitigate short-term risks in referencing that can have long-term consequences

How does it help?

Avoid surprises for Boards of management e.g., supply shortages due to unanticipated parallel trade and price erosion

Supports planning, to mitigate short term risks in referencing that can have long term consequences

Peace of mind as validation of your assumptions and business decisions

Price

MAP Online member fee: £12,000, non-member fee: £25,000

CareersTerms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number:
GB 292 8576 52